Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Carolyn Bigbee"'
Autor:
Saverio Capuano, JoAnne L. Flynn, Philana Ling Lin, Carolyn Bigbee, Le'Kneitah Smith, Amy J. Myers, Matthew Bigbee, Ion Chiosea, Carl R. Fuhrman, Mark Rodgers, Edwin Klein
Publikováno v:
Infection and Immunity. 77:4631-4642
We previously described that low-dose Mycobacterium tuberculosis infection in cynomolgus macaques results in a spectrum of disease similar to that of human infection: primary disease, latent infection, and reactivation tuberculosis (S. V. Capuano III
Autor:
Robert M DiFazio, Pauline Maiello, Jaime Tomko, Lonnie Frye, Carolyn Bigbee, Chelsea Chedrick, Cassaundra Updike, Philana Lin, Else Marie Agger, Peter Andersen, JoAnne L Flynn
Publikováno v:
The Journal of Immunology. 196:146.20-146.20
The only licensed vaccine (BCG) for tuberculosis (TB) has variable efficacy and does not protect against pulmonary TB. New vaccines are in development and in human clinical trials. However, vaccine trials are long and expensive without useful surroga
Autor:
Jes Dietrich, Mark Rodgers, Esterlina V. Tan, David R. Sherman, Matthew Bigbee, Hannah P. Gideon, Kristi M. Guinn, Catherine Cochran, JoAnne L. Flynn, Edwin Klein, Leslie Milk, Christopher Janssen, Rodolfo M. Abalos, Philana Ling Lin, Carolyn Bigbee, Peter Andersen, Jasmin Burgos
It is estimated that one-third of the world’s population is infected with Mycobacterium tuberculosis. Infection typically remains latent, but it can reactivate to cause clinical disease. The only vaccine, Mycobacterium bovis bacillus Calmette-Gueri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3c110b16f120bbffeafeba8f8673039
https://europepmc.org/articles/PMC3248283/
https://europepmc.org/articles/PMC3248283/
Autor:
P. Ling Lin, Carolyn Bigbee, JoAnne L. Flynn, Kale S. Bongers, Joshua T. Mattila, Angela M. Green
Publikováno v:
The Journal of infectious diseases. 202(4)
Mycobacterium tuberculosis infection in humans results in either latent infection or active tuberculosis. We sought to determine whether a higher frequency of regulatory T (T(reg)) cells predispose an individual toward active disease or whether T(reg
Autor:
Helen G. Haggerty, Carolyn Bigbee, JoAnne L. Flynn, Steven G. Nadler, Daryl G. Gonchoroff, George Vratsanos
Publikováno v:
Arthritis and rheumatism. 56(8)
Objective Treatment of rheumatoid arthritis and other autoimmune disorders with anti–tumor necrosis factor (anti-TNF) agents is associated with an increased risk of reactivation of latent Mycobacterium tuberculosis. While the mechanism of action of
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 176(7)
Tuberculosis is the number one cause of death due to infectious disease in the world today. Understanding the dynamics of the immune response is crucial to elaborating differences between individuals who contain infection vs those who suffer active d
Autor:
Robert DiFazio, Hannah Gideon, Teresa Coleman, Pauline Maiello, Lonnie Frye, Jaime Tomko, Melanie O'Malley, Paul Johnston, Daniel Fillmore, Mark Rodgers, Carolyn Bigbee, Chelsea Chedrick, Philana Lin, JoAnne Flynn
Publikováno v:
The Journal of Immunology. 192:141.19-141.19
The only licensed vaccine (BCG) for tuberculosis (TB) has variable efficacy and does not protect against pulmonary TB. New vaccines are in development and in human clinical trials. However, vaccine trials are long and expensive without useful surroga
Autor:
Stephanie Casino, Andre Samuels, Carolyn Bigbee, JoAnne L. Flynn, Jaime Tomko, Edwin Klein, Jennifer Kerr, David Litvin, Philana Ling Lin, Keith A. Reimann, Joshua Matilla, Le'Kneitah Smith
Publikováno v:
The FASEB Journal. 22:497-497